Darwin Biosciences

We’re infectious disease specialists with a contagious sense of curiosity.

About

Darwin Biosciences was founded in March of 2020, just weeks before the Covid-19 pandemic led to nationwide shutdowns. This was a call-to-arms for infectious disease researchers everywhere. We leveraged our expertise in handling and processing human saliva to quickly develop and deploy a turnkey solution to SARS-CoV-2 testing that propelled us through an initial growth phase. We have now turned our focus to developing a next generation diagnostic platform to prepare the world for any unexpected pathogen threat. Darwin is equipped with technology licensed from the University of Colorado Boulder.

Our Founders

Sara Sawyer, Camille Paige, Qing Yang, Nick Meyerson.

Culture

Curiosity is at our core. It’s perhaps the strongest virtue we derive from our namesake. We’re inspired by the natural systems that have evolved to protect our species – we work to leverage their powers every day.

Every member of our team knows their ideas will be heard. Our specialists are encouraged to ‘step out of their lanes.’ We believe the collaborative environment we’re building will directly facilitate our next big breakthrough.

Despite the seriousness of the work we do, we manage to have fun doing it – We actively set aside time for it. Darwin is a fast-growing, youthful organization that rewards ambition and entrepreneurial thinking.

Team

We are bright-eyed experts in the fields of infectious disease, immunology, molecular biology, and healthcare product design. We have extensive experience with analyzing human saliva to detect signatures of infectious disease, with a focus on pre-symptomatic detection of infection. While the Covid-19 pandemic taught the world that a person could be infected and contagious without knowing it, we at Darwin appreciate that this is true for most infectious diseases and are thus striving to create products that ‘shift diagnostics to the left,’ allowing for the early detection of any infection.

Adam Nekimken, Ph.D.

Senior Device Engineer

Amy Emerman, Ph.D.

Director of Product Development

Camille Paige

Co-Founder and Director of Clinical Research

Jennifer Bjerke, Ph.D.

Senior Scientist

Jordan Hoffman

Chief Operating Officer

Josh Dye

Associate Scientist

Kristen Eller, Ph.D.

Senior Scientist

Kyle Clark

Associate Scientist

Nicholas Meyerson, Ph.D.

CEO and Co-Founder

Phil Fox

Head of Assay Development

Qing Yang, Ph.D.

Co-Founder

Rebecca Blackwood

Associate Scientist

Sara Sawyer, Ph.D.

Director and Co-Founder